Rushworth, D
Alpert, A
Santana-Carrero, R
Olivares, S
Spencer, D
Cooper, L J N
Article History
Received: 28 April 2015
Revised: 11 July 2015
Accepted: 5 August 2015
First Online: 14 August 2015
Competing interests
: Dr Cooper founded and owns InCellerate Inc. He has patents with Sangamo BioSciences on artificial nucleases. He consults with Targazyme Inc. (formerly American Stem Cells Inc.), GE Healthcare, Ferring Pharmaceuticals Inc. and Bristol-Myers Squibb. Dr Cooper receives honoraria from Miltenyi Biotec. He has agreed to license technologies developed in his laboratory to Intrexon Corp. and Ziopharma Oncology Inc. He has numerous patents in the field of immunotherapy and genetic engineering.